Displaying 1 - 5 of 5 tests
U2AF1 Mutation Analysis
Bi-directional sequencing of exons 2 and 7 of the U2AF1 gene (also called U2AF35).
Molecular
UGT1A1 Genotyping
Lengths of the TA repeat polymorphism in the promoter region of the UTG1A1 gene are determined by fragment analysis using capillary electrophoresis. The alleles detected include the common normal allele *1 (with 6 TA repeats) and the common abnormal allele *28 (7 repeats). The patient's genotype is
Molecular
Universal Fusion/Expression Profile
The Universal Fusion/Expression Profile is a targeted RNA sequencing panel that utilizes next-generation sequencing (NGS) to detect all relevant fusion transcripts in 1,385 genes associated with hematologic or solid tumor cancers. It is especially useful for testing patients with rare diseases.
Molecular
Uroplakin II
Uroplakin II is a 15 kDa protein component of urothelial plaques. Uroplakin II mRNA was found in both bladder cancer tissues and peripheral blood of patients with primary and metastatic urothelial carcinoma of the bladder. Uroplakin II antibody [BC21] is a highly specific antibody that may be useful
Immunohistochemistry (IHC)
Uroplakin III
Uroplakins (UPs) are a family of transmembrane proteins (UPs Ia, Ib, II and III) that are specific differentiation products of urothelial cells. In non-neoplastic urothelium, UPIII is expressed in the luminal surface plasmalemma of superficial (umbrella) cells. UPIII detects half of urothelial
Immunohistochemistry (IHC)